Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Holstein

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Thrombosis Research|October 23, 2016
Current view and outcome of ITI therapy - A change over time?K Holstein, A Batorova, M Carvalho, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2011
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendationsC Hermans, P De Moerloose, K Fischer, et al.
Journal of Thrombosis and Haemostasis : JTH|March 19, 2016
Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 studyS Werwitzke, U Geisen, U Nowak-Göttl, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 29, 2015
Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq<sup>®</sup> ) in adults with severe haemophilia A: efficacy and safetyT Lissitchkov, K Hampton, M von Depka, et al.
Hamostaseologie|November 8, 2011
Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia BI Wieland, C Wermes, B Eifrig, et al.
Hamostaseologie|November 5, 2008
Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia AI Wieland, C Wermes, B Eifrig, et al.
Bone Marrow Transplantation|October 24, 2000
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemiaN Kröger, T Zabelina, S Sonnenberg, et al.
Seminars in Oncology|May 13, 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, J Beyer, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Thrombosis Research|October 23, 2016
Current view and outcome of ITI therapy - A change over time?K Holstein, A Batorova, M Carvalho, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2011
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendationsC Hermans, P De Moerloose, K Fischer, et al.
Journal of Thrombosis and Haemostasis : JTH|March 19, 2016
Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 studyS Werwitzke, U Geisen, U Nowak-Göttl, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 29, 2015
Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq<sup>®</sup> ) in adults with severe haemophilia A: efficacy and safetyT Lissitchkov, K Hampton, M von Depka, et al.
Hamostaseologie|November 8, 2011
Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia BI Wieland, C Wermes, B Eifrig, et al.
Hamostaseologie|November 5, 2008
Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia AI Wieland, C Wermes, B Eifrig, et al.
Bone Marrow Transplantation|October 24, 2000
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemiaN Kröger, T Zabelina, S Sonnenberg, et al.
Seminars in Oncology|May 13, 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, J Beyer, et al.
Pageof 2